RxSight, Inc. (RXST)

NASDAQ: RXST · IEX Real-Time Price · USD
+1.06 (8.04%)
At close: Jan 27, 2023, 4:00 PM
+0.71 (4.98%)
After-hours: Jan 27, 2023, 7:11 PM EST

Company Description

RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally.

It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery.

The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery.

It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017.

RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

RxSight, Inc.
RxSight logo
Country United States
Founded 1997
IPO Date Jul 30, 2021
Industry Medical Devices
Sector Healthcare
Employees 221
CEO Dr. Ronald M. Kurtz M.D.

Contact Details

100 Columbia Street, Suite 120
Aliso Viejo, California 92656
United States
Phone 949-521-7822
Website rxsight.com

Stock Details

Ticker Symbol RXST
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $16.00
CIK Code 0001111485
CUSIP Number 78349D107
ISIN Number US78349D1072
Employer ID 94-3268801
SIC Code 3851

Key Executives

Name Position
Dr. Ronald M. Kurtz M.D. President, Chief Executive Officer and Director
Shelley B. Thunen Chief Financial Officer and Assistant Secretary
Dr. Ilya Goldshleger Ph.D. Chief Operating Officer
Eric J. Weinberg Chief Commercial Officer
Rebecca Williston Vice President of Accounting and Finance
Matt Haller Ph.D. Chief Technology Officer
Steve Everly Vice President of US Sales
Roy Freeman Vice President of Marketing
Caroline Vaughn Vice President of Human Resources
Scott Gaines Senior Vice President of Commercial Operations and Business Process

Latest SEC Filings

Date Type Title
Jan 9, 2023 8-K Current Report
Dec 12, 2022 8-K Current Report
Nov 7, 2022 10-Q Quarterly Report
Nov 7, 2022 8-K Current Report
Aug 12, 2022 EFFECT Notice of Effectiveness
Aug 12, 2022 424B5 Filing
Aug 8, 2022 8-K Current Report
Aug 8, 2022 S-3 Registration statement under Securities Act of 1933
Aug 8, 2022 10-Q Quarterly Report
Aug 8, 2022 8-K Current Report